HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PTSD risk associated with a functional DRD2 polymorphism in heroin-dependent cases and controls is limited to amphetamine-dependent individuals.

Abstract
Posttraumatic stress disorder (PTSD), a pathologic response to severe stress, is a common co-morbid disorder in substance-dependent individuals. Evidence from twin studies suggests that PTSD is moderately heritable. Genetic association studies to date have reported a limited number of replicated findings. We conducted a candidate gene association study in trauma-exposed individuals within the Comorbidity and Trauma Study's sample (1343 heroin-dependent cases and 406 controls from economically disadvantaged neighborhoods). After data cleaning, the 1430 single nucleotide polymorphisms (SNPs) retained for analyses provided coverage of 72 candidate genes and included additional SNPs for which association was previously reported as well as 30 ancestry-informative markers. We found a functional DRD2 promoter polymorphism (rs12364283) to be most highly associated with PTSD liability [odds ratio (OR) 1.65 (1.27-2.15); P = 1.58 × 10(-4) ]; however, this association was not significant, with a stringent Bonferroni correction for multiple comparisons. The top hits include SNPs from other dopaminergic system genes: DRD2 DRD3, TH and DBH. Additional analyses revealed that the association involving rs12364283 is largely limited to amphetamine-dependent individuals. Substantial risk is observed in amphetamine-dependent individuals, with at least one copy of this SNP [OR 2.86 (1.92-4.27); P = 2.6 × 10(-7) ]. Further analyses do not support extensive mediation of PTSD risk via self-reported impulsivity (BIS total score). These findings suggest roles for impairment in inhibitory control in the pathophysiology of PTSD and raise questions about stimulant use in certain populations (e.g. those in combat).
AuthorsElliot C Nelson, Andrew C Heath, Michael T Lynskey, Arpana Agrawal, Anjali K Henders, Lisa M Bowdler, Alexandre A Todorov, Pamela A F Madden, Elizabeth Moore, Louisa Degenhardt, Nicholas G Martin, Grant W Montgomery
JournalAddiction biology (Addict Biol) Vol. 19 Issue 4 Pg. 700-7 (Jul 2014) ISSN: 1369-1600 [Electronic] United States
PMID23647975 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2013 Society for the Study of Addiction.
Chemical References
  • DRD2 protein, human
  • Receptors, Dopamine D2
Topics
  • Adult
  • Amphetamine-Related Disorders (complications, genetics)
  • Australia
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease (genetics)
  • Heroin Dependence (complications, genetics)
  • Humans
  • Male
  • Polymorphism, Single Nucleotide (genetics)
  • Receptors, Dopamine D2 (genetics)
  • Risk
  • Stress Disorders, Post-Traumatic (complications, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: